CONTEXT THERAPEUTICS INC (CNTX) Stock Earnings & Estimates
USA - NASDAQ:CNTX - US21077P1084 - Common Stock
1.36 USD
+0.1 (+7.94%)
Full estimates are only available for subscribed users, you can see which data is available below.
Subscribed users also see more surprise data, now it is restricted to 4 quarters.
Examples of complete estimate data are available for MSFT and AAPL.
Registered users have access to more data. Please register or login for additional estimates and surprises .
| 2016 | 2017 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY % growth | N/A | N/A | N/A | N/A | N/A 488.80% | N/A 181.08% | N/A 130.11% | N/A 64.58% | |||||||||
| EBITDA YoY % growth | -33.19M | -24.04M 27.57% | N/A | N/A | N/A | -15.37M -43.23% | -25.061M -63.05% | -29.913M -19.36% | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | |
| EBIT YoY % growth | -33.23M | -24.06M 27.60% | -5.38M | -2.57M 52.23% | -10.53M -309.73% | -15.38M -46.06% | -25.073M -63.02% | -29.924M -19.35% | N/A -16.22% | N/A -21.74% | N/A -30.10% | N/A -12.43% | N/A 22.92% | N/A 101.70% | N/A 11,151.20% | N/A 139.89% | |
| Operating Margin | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | |
| EPS YoY % growth | N/A | N/A | N/A | N/A | N/A | -0.93 90.13% | -1.50 -61.29% | -0.53 64.67% | N/A 35.12% | N/A -30.38% | N/A 3.31% | N/A 5.88% | N/A 53.50% | N/A 230.11% | N/A 383.47% | N/A 71.79% |
All data in USD
| Q3 / 25 | Q4 / 25 | Q1 / 26 | Q2 / 26 | Q3 / 26 | Q4 / 26 | Q1 / 27 | Q2 / 27 | Q3 / 27 | Q4 / 27 | Q1 / 28 | Q2 / 28 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| EPS Q2Q % growth | -0.10 56.02% | -0.10 -153.90% | -0.12 -131.19% | -0.12 -29.96% | -0.12 -27.56% | -0.12 -19.51% | -0.07 38.23% | -0.10 12.79% | -0.13 -7.44% | -0.15 -26.05% | -0.22 -207.14% | -0.26 -150.00% |
| Revenue Q2Q % growth | N/A | N/A | N/A | N/A | N/A | N/A | ||||||
| EBITDA Q2Q % growth | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| EBIT Q2Q % growth | -9.463M 49.40% | -9.732M -125.79% | -9.282M -67.88% | -9.384M 3.84% | -9.486M -0.25% | -10.098M -3.76% | N/A | N/A | N/A | N/A | N/A | N/A |
All data in USD
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q2 2025 Q2Q % growth | -0.09 -125.00% | -0.06 | -0.03 | -44.18% |
| Q1 2025 Q2Q % growth | -0.05 78.26% | -0.06 | 0.01 | 15.19% |
| Q4 2024 Q2Q % growth | -0.04 90.48% | -0.09 | 0.05 | 57.74% |
| Q3 2024 Q2Q % growth | -0.22 40.54% | -0.11 | -0.11 | -105.42% |
| Q2 2024 Q2Q % growth | -0.04 87.10% | -0.08 | 0.04 | 47.71% |
| Q1 2024 Q2Q % growth | -0.23 42.50% | -0.45 | 0.22 | 48.75% |
| Q4 2023 Q2Q % growth | -0.42 -90.91% | -0.36 | -0.06 | -17.65% |
| Q3 2023 Q2Q % growth | -0.37 -54.17% | -0.32 | -0.05 | -17.01% |
| Q2 2023 Q2Q % growth | -0.31 -24.00% | -0.20 | -0.11 | -51.96% |
| Q1 2023 Q2Q % growth | -0.40 -81.82% | -0.19 | -0.21 | -106.40% |
| Q4 2022 Q2Q % growth | -0.22 -5.21% | -0.30 | 0.08 | 26.89% |
| Q3 2022 Q2Q % growth | -0.24 | -0.26 | 0.02 | 5.88% |
| Q2 2022 Q2Q % growth | -0.25 | -0.26 | 0.01 | 1.96% |
| Q1 2022 Q2Q % growth | -0.22 | -0.24 | 0.02 | 10.13% |
| Period | Reported | Estimate | Difference | Surprise |
|---|
| Next Q (1 month) | Next Q (3 month) | Next Year (1 month) | Next Year (3 month) | |
|---|---|---|---|---|
| EPS | -2.74% | -41.16% | -3.42% | -37.47% |
| Revenue | N/A | N/A | N/A | N/A |